Cardiac Arrhythmias 1999: Vol.1. Proceedings of the 6th International Workshop on Cardiac Arrhythmias (Venice, 5–8 October 1999)

ISBN-13: 9788847021785 / Angielski / Miękka / 2012 / 591 str.

M.D. Antonio Raviele

Opis

This book, consisting of two volumes, contains the Proceedings of the 6th International Workshop on Cardiac Arrythmias held in Venice, Italy at the Fondazione Giorgio Cini, on 5-8 October 1999. Over the four days of the meet ing, practically all aspects of heart rhythm disorders were addressed and dis cussed by internationally renowned experts and by the numerous participants coming from all around the world. Volume 1 - which will be distributed by the international book trade - comprises the contributions of the structured sym posia, while Volume 2 contains those of the satellite symposia. This second vol ume will exclusively be available to the participants of the workshop. On the whole, I believe the book represents the state of our present knowledge about cardiac arrhythmias and antiarrhythmic therapy. The main topics dealt with in the two volumes include: molecular pathology of cardiac arrhythmias; atrial fibrillation with its different pathophysiological, electrophysiological, clinical and therapeutic aspects; atrial flutter and other supraventricular tachyarrhythmias; ventricular arrhythmias, with particular focus on malignant, idiopathic and uncommon forms; non-antiarrhythmic and antiarrhythmic measures for prevention of sudden death; technological advances and clinical aspects of ICD therapy; modern evaluation of patients with syncope; and, finally, cardiac pacing with practical issues, controversial indications, usefulness of different pacing modes and sites of stimulation and, in particular, usefulness of left ventricular or biventricular pacing for treat ment of heart failure. Many individuals have contributed to the realization of this book."

Spis treści

Lectures.- Sudden Ischemic Cardiac Death: The Clinical Approach.- Molecular Pathology of Cardiac Diseases Liable to Cause Sudden Death.- Atrial Fibrillation.- Are All Paroxysms of Atrial Fibrillation Focally Initiated?.- How Common Is a Genetic Origin of Atrial Fibrillation?.- Lone Atrial Fibrillation: What Is the Anatomical and the Electrophysiological Substrate?.- Atrial Fibrillation in Apparently Idiopathic Cardiomyopathy: The Chicken or the Egg?.- Cardioversion for Atrial Fibrillation Today: When and Why?.- Acute Conversion of Recent-Onset Atrial Fibrillation and Flutter: Class IC or Class III Drugs?.- Antiarrhythmic Drug Therapy Before Electrical Cardioversion of Atrial Fibrillation: Is It Really Useful?.- Low-Energy Internal Defibrillation: How Many Patients Are Still in Sinus Rhythm After 1 Year?.- How Useful Is Transoesophageal Echocardiography During Electrical Cardioversion for Predicting Long-Term Sinus Rhythm Maintenance?.- Atrial Stunning Following Sinus Rhythm Restoration: Which Mechanism, Time Course and Implication for Anticoagulation?.- Drug Prevention of Atrial Fibrillation: Are Novel Agents More Effective Than the Old Ones?.- Atrial Pacing for Prevention of Atrial Fibrillation: Where and How to Stimulate?.- Implantable Atrial Defibrillator: What are the Results of Initial Experience?.- Implantable Atrial Defibrillator: What Are the Future Perspectives?.- Implantable Atrial Defibrillator: Why not a Patient-Activated Drug Delivery System?.- Ablation of Atrial Fibrillation: How Should Patients Be Selected?.- An Anatomical Approach to Curing Atrial Fibrillation: Pulmonary Vein Isolation with Through-the-Balloon Ultrasound Ablation.- Ablate and Pace Therapy or AV Junction Modification for Medically Refractory Atrial Fibrillation?.- Atrial Fibrillation After Heart Surgery: How to Identify and Protect Predisposed Patients?.- Other Supraventricular Tachycardias.- Clinically Documented but Not Inducible Atrioventricular Nodal Reentrant Tachycardia: To Ablate or Not To Ablate?.- Permanent Junctional Reentry Tachycardia: When to Ablate, Where and With Which Results?.- How to Predict and Avoid Complete AV Block Complicating Radiofrequency Ablation of AV Nodal Slow Pathway.- Ablation of Antero-Septal and Intermediate Septal Accessory Pathways: How Safe Is It? How Can One Minimize the Risk of AV Block?.- Acute Treatment of Atrial Flutter: Ibutilide, Transesophageal Pacing, or DC Shock?.- Chronic Atrial Flutter: What Is the Risk of Thromboembolism?.- Common and Uncommon Atrial Flutter: What Are the Long-Term Results and Complications of Radiofrequency Ablation?.- Atrial Tachycardia Originating from Crista Terminalis.- “Incisional” Reentrant Atrial Tachycardia: How to Prevent and Treat It?.- Treatment of Tachyarrhythmias Using Cryothermal Energy.- Ventricular Arrhythmias.- Idiopathic Ventricular Fibrillation: Is the Prognosis Always Bad?.- The Syndrome of Right Bundle Branch Block, ST Segment Elevation in V1 to V3 and Sudden Death. Are Asymptomatic patients at high risk for sudden death?.- Is Atrial Vulnerability Increased In Arrhythmogenic Right Ventricular Cardiomyopathy?.- Is Right Ventricular Outflow Tract Tachycardia a Minor Form of Arrhythmogenic Right Ventricular Cardiomyopathy?.- Electrophysiologic Mechanisms of Polymorphic Ventricular Tachycardia/Torsade de Pointes in the Presence of Normal or Long QT.- Sudden Infant Death Syndrome and Long-QT Syndrome: What is Their Relationship?.- Brugada and Long QT Syndrome Are Two Different Diseases: True or False?.- Effect of ?-Blocker Therapy on the Frequency and Type of Cardiac Events in Patients with the Hereditary Long QT Syndrome.- Gene Therapy for Long QT Syndrome: Fact or Fiction?.- An Overview of Secondary Prevention Implantable Cardioverter-Defibrillator Trials: AVID, CIDS and CASH.- What Has Been the Impact on Clinical Practice of Recently Published Postevent ICD Trials?.- Is the Implantable Defibrillator Cost-effective?.- What Is the Best Algorithm to Discriminate Between Supraventricular and Ventricular Tachyarrhythmias?.- Transthoracic Epicardial Mapping and Ablation of Post-Infarction Ventricular Tachycardia: The Right Solution to the Problem?.- Sudden Death after Myocardial Infarction.- Risk Stratification for Serious Arrhythmic Events in Post-Infarction Patients.- What Is the Clinical and Prognostic Significance of High-Resting Sinus Rate?.- What is the Relationship Between Depression, the Autonomic Nervous System and the Risk of Death in Post-Myocardial Infarction Patients?.- Does Baroreflex Sensitivity Add Something to Noninvasive Evaluation of Post-Infarction Patients?.- Does Electrophysiologic Study Allow Further Risk Stratification in Survivors of Acute Myocardial Infarction?.- The BEST + ICD Trial: Is ICD Also Effective in the Presence of Optimized ?-Blocking Therapy?.- SEDET Trial: Is Noninvasive Evaluation Sufficient to Identify Patients at High Risk of Arrhythmia?.- DINAMIT: Does ICD Implantation Improve Life Expectancy in Survivors of Acute Myocardial Infarction?.- What Are the Clinical Implications of MUSTT?.- ALIVE Trial: How Is This Trial Design Different?.- Syncope.- What is the Value of Clinical History in Establishing the Cause of Syncope?.- Adenosine-Sensitive Syncope: Does it Really Exist?.- Idiopathic Postural Orthostatic Tachycardia: A Variant of Neurocardiogenic Syncope?.- Syncope of Unknown Origin After Electrophysiologic Study and Head-Up Tilt Test: How Useful is an Implantable Loop Recorder?.- Nitrotest Versus Isotest for Vasovagal Syncope: Do They Explore Different Mechanisms?.- Is the Type of Cardiovascular Response During Tilt Table Testing Useful for the Choice of the Treatment? The New VASIS Classification.- Midodrine for Treatment of Vasovagal Syncope.- Vasovagal Syncope: To Pace or not to Pace?.- Patient-Activated Implantable Drug Delivery System for Treatment of Vasovagal Syncope: A Simple Solution?.- Pacemaker.- Lead Extraction: How Easy and Safe Is It Today?.- Pacemaker/ICD Patients: To Anticoagulate or Not To Anticoagulate?.- How Risky Are Cellular Telephones for Patients Implanted with a Pacemaker or ICD?.- What Are the Risks for Pacemaker/ICD Patients Undergoing Magnetic Resonance Imaging or Other Medical Procedures?.- Pacemaker Treatment for Hypertrophic Obstructive Cardiomyopathy: Are Long-Term Results as Good as Short-Term Ones?.- Theophylline for Treatment of Bradyarrhythmias: When Is it Indicated?.- SSS Patients: Atrial or Dual-Chamber Pacing?.- Mobitz I AV Block: Why and When to Pace?.- Patients Implanted for AV Block: How Many Subsequently Develop Sinus Node Dysfunction?.- Optimizing the AV Delay in DDD Pacemakers: How Useful Is it?.- What Are the Long-Term Benefits of the Dual-Chamber Rate-Responsive System Driven by Contractility?.- Haemodynamic Sensors: What is Their Role in Monitoring Heart Function?.- What Is the Optimal Site for Right Ventricular Pacing: Outflow Tract or Apex?.- Treatment of Severe Heart Failure: Is Left Ventricular Pacing Alone Enough or Do We Need Biventricular Pacing?.- Multisite Biventricular Pacing to Treat Refractory Heart Failure: Why and How?.- Biventricular Pacing: Is Acute Hemodynamic Evaluation Useful to Select Patients?.